XML 73 R55.htm IDEA: XBRL DOCUMENT v3.8.0.1
Supplementary Information - Quarterly Results of Operations (Tables)
 12 Months Ended
Dec. 31, 2017
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Information [Table Text Block] The following table summarizes our unaudited quarterly financial data for 2017 and 2016 (in thousands, except per share amounts):
 
Quarter Ended
 
 
 
March 31
 
June 30
 
September 30
 
December 31
 
Total
2017
 
 
 
 
 
 
 
 
 
Net sales
$
113,252

 
$
77,029

 
$
88,132

 
$
127,771

 
$
406,184

Gross profit
61,745

 
38,378

 
41,315

 
62,444

 
203,882

Operating income(1)
12,683

 
3,849

 
13,365

 
6,406

 
36,303

Income from continuing operations(2)
8,185

 
2,566

 
8,342

 
8,532

 
27,625

Loss from discontinued operations(3)
(1,092
)
 
(77
)
 
(101
)
 
(88
)
 
(1,358
)
Net income
7,093

 
2,489

 
8,241

 
8,444

 
26,267

Net income per share:
 
 
 
 
 
 
 
 
 
Basic
$
0.23

 
$
0.08

 
$
0.27

 
$
0.28

 
$
0.86

Diluted
0.23

 
0.08

 
0.27

 
0.27

 
0.85

 
 
 
 
 
 
 
 
 
 
2016
 
 
 
 
 
 
 
 
 
Net sales
$
120,928

 
$
78,529

 
$
80,818

 
$
125,764

 
$
406,039

Gross profit
66,344

 
41,862

 
39,217

 
64,102

 
211,525

Operating income
19,300

 
6,573

 
8,211

 
19,310

 
53,394

Income from continuing operations(4)
11,586

 
3,696

 
7,845

 
11,974

 
35,101

Loss from discontinued operations
(142
)
 
(166
)
 
(251
)
 
(364
)
 
(923
)
Net income
11,444

 
3,530

 
7,594

 
11,610

 
34,178

Net income per share:
 
 
 
 
 
 
 
 
 
Basic
$
0.37

 
$
0.11

 
$
0.24

 
$
0.38

 
$
1.10

Diluted
0.37

 
0.11

 
0.24

 
0.37

 
1.09


(1) Operating income for the quarter ended December 31, 2017 included an $8.8 million non-cash asset impairment charge related to the Octane Fitness brand name.

(2) Income from continuing operations for the quarter ended December 31, 2017 included a non-recurring tax benefit of $5.6 million related to the change in U.S. tax law that resulted in the reassessment of certain deferred tax assets and liabilities.

(3) Loss from discontinued operations for the quarter ended March 31, 2017 included a $1.2 million expense related to a lawsuit settlement with Biosig Instruments, Inc.

(4) Income from continuing operations for the quarter ended September 30, 2016 included a non-recurring tax benefit of $2.7 million related to the release of previously unrecognized tax benefits associated with certain non-U.S. filing positions, which resulted from completing the deregistration of a certain foreign entity.